[{"data":1,"prerenderedAt":487},["ShallowReactive",2],{"content-site-settings":3,"site-map-\u002Fsite-map":73,"site-map-locations":486},{"id":4,"extension":5,"meta":6,"stem":71,"__hash__":72},"dataFiles\u002Fdata\u002Fsite.json","json",{"en":7},{"siteDetails":8,"cookieControl":12,"siteLogo":16,"mainNav":21,"preNav":37,"stickyNav":60,"footerContent":61},{"organisationName":9,"siteName":10,"siteUrl":11},"University of Oxford","ROBUST study site","https:\u002F\u002Frobust-study.org",{"cookieModalTitle":13,"cookieModalText":14,"nonNecessaryCookiesUsed":15},"Cookies used on this site","This website only uses non-necessary cookies to remember where you are in the process and to learn about how people view the information. We do NOT use cookies that directly identify anyone. For the best experience please click Accept all below.",true,{"url":17,"alt":18,"width":19,"height":20},"robust-logo.svg","Home",274.7,48,[22,24,27,31,34],{"title":18,"url":23},"\u002F",{"title":25,"url":26},"Taking part","\u002Ftaking-part",{"title":28,"url":29,"target":30,"external":30},"About the study","\u002Fabout\u002F",false,{"title":32,"url":33},"Resources","\u002Fresources\u002F",{"title":35,"url":36,"target":30,"external":30},"Contact","\u002Fcontact\u002F",[38,43,46,50,53,57],{"id":39,"url":40,"title":41,"visibleFrom":42},"prenav-1","https:\u002F\u002Fredcap-ndormssitu.octru.ox.ac.uk\u002F","Enrolment & Data Collection","md",{"id":44,"url":40,"title":45,"visibleBelow":42},"prenav-2","REDCap",{"id":47,"url":48,"title":49,"visibleFrom":42},"prenav-3","https:\u002F\u002Frobust-info.digitrial.com\u002F","Patient Information Tool",{"id":51,"url":48,"title":52,"visibleBelow":42},"prenav-4","PIT",{"id":54,"url":55,"title":56,"visibleFrom":42},"prenav-5","https:\u002F\u002Frobust-app.digitrial.com\u002F","Intervention App",{"id":58,"url":55,"title":59,"visibleBelow":42},"prenav-6","App",[],{"footerLogo":62,"footerCol1":67,"footerCol2":68,"footerCol3":69,"additionalInfo":70},{"url":63,"alt":64,"width":65,"height":66},"robust-footer-logo.svg","MEDICAL TRIAL study logo",352,180,"**Address**\nNDORMS\nUniversity of Oxford\nBotnar Research Centre\nWindmill Road\nOxford OX3 7LD","**Email**\nROBUST@ndorms.ox.ac.uk\n\n**Telephone**\n07584155471","[Privacy policy](\u002Fprivacy)\n[Cookie policy](\u002Fcookies)\n[Accessibility statement](\u002Faccessibility)\n[Site map](\u002Fsite-map)","The ROBUST Study is funded by the National Institute for Health and Care Research (Funder Reference: NIHR135150). The views expressed are those of the authors and are not intended to be representative of the views of the funder, sponsor or other participating organisations.\n\nThe information contained in this website is for general information about the ROBUST Study and is provided by the University of Oxford (Surgical Intervention Trials Unit).\n\n**This is a digitrial site made by morph.co.uk.**","data\u002Fsite","-4HWatMdsU67tUixcTKUO6DECjs_ggq52ZNrTylZJ5c",[74,210,231,265,290,381,402,446],{"id":75,"title":28,"body":76,"description":76,"extension":5,"meta":77,"navigation":15,"path":206,"seo":207,"stem":208,"__hash__":209},"contentPages\u002Fpages\u002Fabout.en.json",null,{"pageTitle":28,"pageMetadata":78,"page_content":79},{"htmlTitle":28,"htmlDesc":28},[80,92,102,108,151,190,198],{"type":81,"title":82,"text":83,"image":84,"settings":89,"sectionSettings":91},"page_header","# About the study","Clinical effectiveness of an adolescent-specific strengthening programme, compared to usual care, for ambulant adolescents with spastic cerebral palsy (ROBUST trial): a parallel group randomised controlled trial.",{"url":85,"alt":86,"width":87,"height":88},"robust-header-image-2.svg","",1000,655,{"imgPosition":90},"bottom",{"sectionLabel":28},{"type":93,"settings":94,"title":96,"text":97,"image":98,"sectionSettings":100},"text_and_image",{"imgWidth":95,"imgPosition":90},"half-width","## Aim of the study","The aim of this study is to assess if an exercise programme to strengthen the muscles of young people with cerebral palsy is better than their usual physiotherapy treatment.",{"url":99,"alt":86,"width":87,"height":88},"robust-content-image-19.svg",{"sectionLabel":101},"Aim of the study",{"type":103,"text":104,"componentName":105,"sectionSettings":106},"text_and_component","## Enrolment curve","StudyRecruitmentChart",{"sectionLabel":107},"Current enrolment curve",{"type":109,"settings":110,"text":115,"cards":116,"sectionSettings":149},"text_and_cards",{"headerLevel":111,"headerFontSize":112,"maxCardsPerRow":111,"wholeClickable":30,"cardTheme":113,"alignCards":114,"alignCardContent":114},"3","4","primary","center","## Information about the Study",[117,124,129,134,139,144],{"type":118,"icon":119,"title":122,"summary":123},"card_icon_text",{"iconName":120,"iconSize":121},"content-edit","xl","Study Design","A multi-centre, two arm, parallel design, superiority, randomised controlled trial. The participants will be individually randomised (1:1) to receive either a strengthening intervention programme or usual NHS care.",{"type":118,"icon":125,"title":127,"summary":128},{"iconName":126,"iconSize":121},"content-person","Target population","Adolescents from 12 to 18 years of age (i.e. from their 12th to their 18th birthday) with a diagnosis of spastic cerebral palsy (bilateral or unilateral) Gross Motor Function Classification System (GMFCS) levels I–III who are able to comply with assessment procedures and exercise programme with or without support from their carer.",{"type":118,"icon":130,"title":132,"summary":133},{"iconName":131,"iconSize":121},"content-seedling","Study Funder and Sponsor","The trial is funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment (HTA) programme. The sponsor is University of Oxford, Research Governance, Ethics & Assurance Team (RGEA).",{"type":118,"icon":135,"title":137,"summary":138},{"iconName":136,"iconSize":121},"content-cross","Intervention","Progressive resistance exercise programme: Participants receive an individually tailored strengthening programme, including structured resistance exercises and advice, overseen by a physiotherapist with 6 one-to-one sessions over 16 weeks.",{"type":118,"icon":140,"title":142,"summary":143},{"iconName":141,"iconSize":121},"content-calendar","Timescales","Planned trial period is 44 months.\n\nRecruitment is expected to last for 20 months.",{"type":118,"icon":145,"title":147,"summary":148},{"iconName":146,"iconSize":121},"content-pie-chart","Outcome Measures","Functional mobility at 6 months measured using the patient\u002Fparent reported GOAL (Gait Outcomes Assessment List) questionnaire",{"sectionLabel":150},"Information about the Study",{"type":109,"settings":152,"text":154,"cards":155,"sectionSettings":188},{"headerLevel":111,"headerFontSize":112,"maxCardsPerRow":111,"wholeClickable":30,"cardTheme":113,"numberedCards":30,"alignCards":153,"alignCardContent":153},"left","## Core Trial Team",[156,163,168,173,178,183],{"type":157,"image":158,"title":161,"summary":162},"card_image_text",{"url":159,"width":160,"height":160},"tim-theologis.jpg",450,"Tim Theologis","**Co-Chief Investigator**\n\nProf Tim Theologis is a Senior Research Fellow at Oxford University and an honorary Consultant Orthopaedic Surgeon at Oxford University Hospitals. He looks after children with orthopaedic conditions and is involved in the teaching of medical students, the supervision of postgraduate degrees and the training of orthopaedic residents. He has an active academic interest in children’s orthopaedics and is leading multi-centre clinical research studies.",{"type":157,"image":164,"title":166,"summary":167},{"url":165,"width":160,"height":160},"sally-hopewell.jpg","Professor Sally Hopewell","**Co-Chief Investigator**\n\nMy key areas of research expertise are in the design, conduct and transparent reporting of randomized trials and systematic reviews. I am involved in leading the design and delivery of a number of clinical trials within the OCTRU portfolio. I am also co-chief investigator on the SPELL and ROBUST trials and on several other NIHR funded trials in the areas of rehabilitation and musculoskeletal sciences.",{"type":157,"image":169,"title":171,"summary":172},{"url":170,"width":160,"height":160},"catherine.jpg","Catherine Barry","**Paediatric Research Physiotherapist**\n\nI joined the Surgical Intervention Trials Unit (SITU-NDORMS) as a Paediatric Research Physiotherapist working on the SPELL and ROBUST trials. Funded by the NIHR Health Technology Assessment programme, the trials investigate the clinical effectiveness of physiotherapy interventions for children and young people with cerebral palsy. \n\nAfter graduating with a BSc (Hons) in Physiotherapy from the University of Southampton in 1996,  I specialised as a Paediatric Physiotherapist. I developed a specialist interest in the musculoskeletal management of cerebral palsy, including rehabilitation following lower limb multi-level orthopaedic surgery, working in both Melbourne and Oxford Children’s Hospital.  My most recent clinical role was as an Extended Scope Physiotherapist (in paediatric neuro-orthopaedics), which I combined with the role of Children’s Musculoskeletal Therapy Team Lead at The Oxford University Hospitals NHS Foundation Trust.",{"type":157,"image":174,"title":176,"summary":177},{"url":175,"width":160,"height":160},"helen.jpg","Helen Wood","**Physiotherapist (Research)**\n\nI joined SITU in 2023 as a research physiotherapist to work on the SPELL and ROBUST clinical trials.  I continue to work clinically alongside this.  \n\nPrior to taking up this role I worked clinically in variety of sectors, specialising initially in Adult and Paediatric MSK.  I completed an MSc in Paediatric Physiotherapy at UCL before moving to Oxford where I spent time working in both the paediatric acute, and MSK\u002Forthopaedic teams.  Here, I was fortunate to complete a research internship, funded by the Oxford Biomedical Research Centre.",{"type":157,"image":179,"title":181,"summary":182},{"url":180,"width":160,"height":160},"jo.jpg","Jo O’Mahoney","**Clinical Trial Manager**\n\nI joined SITU in November 2021 to work as a trial manager on the paediatric orthopaedic CPinBOSS study. CPinBOSS is a cohort study measuring the number of patients with cerebral palsy eligible for single event multi level surgery (SEMLS) in the UK. This study is led by Chief Investigator Tim Theologis and is now in follow up. In addition, I have recently started working on the set up of another paediatric study investigating the role of USS and MRI in diagnosing bone infection - PIC Bone, which is also led by Tim Theologis and Dan Perry (joint Chief Investigators). \r\n\r\nMy background is in psychology in which I have achieved a BSc (Hons) degree, followed by a MSc in Foundations of Clinical Psychology in 2008. I then worked as a research worker on a number of mental health research projects at St George's University of London and King's College Institute of Psychiatry before I returned to my hometown of Oxford where I joined NDORMS in 2014 as a research coordinator. In this role I assisted with the set up and delivery of both adult and paediatric musculoskeletal research projects. This is where I discovered my passion for paediatric orthopaedic research, leading me to my current role. ",{"type":157,"image":184,"title":186,"summary":187},{"url":185,"width":160,"height":160},"debbie-jewell.jpg","Debbie Jewell","**Clinical Trials Coordinator**\n\nI joined the Surgical Intervention Trials Unit (SITU) in April 2024 as a Clinical Trial Coordinator, where I currently support the SPELL and ROBUST Trials, as well as the PIC Bone Study. \n\nPrior to joining SITU, I worked as a Clinical Research Assistant at Milton Keynes University Hospital NHS Foundation Trust. My background is in Psychology, in which I have achieved a BSc (hons) degree in 2018, followed by a MSc in Psychological Research Methods in 2020.",{"sectionLabel":189},"Study Team",{"type":93,"settings":191,"title":192,"text":193,"image":194,"sectionSettings":196},{"imgWidth":95,"imgPosition":90},"## Co-Applicants","* Prof Tim Theologis (University of Oxford)\n* Prof Sally Hopewell (University of Oxford)\n* Prof Jeremy Parr (Newcastle University)\n* Dr Morag Andrew (Newcastle upon Tyne NHS Foundation Trust)\n* Dr David Keene (University of Exeter)\n* Dr Jennifer Ryan (Royal College of Surgeons in Ireland)\n* Dr Lesley Katchburian (UCL Great Ormond Street Institute of Child Health)\n* Mrs Rachel Rapson (Torbay and South Devon NHS Foundation Trust)\n* Dr Ines Rombach (Sheffield University)\n* Dr Beth Fordham (University of Oxford)\n* Mr Gregory Firth (Royal London Hospital)\n* Prof Daniel Perry (University of Liverpool)\n* Ms Vivi Gregory-Osborne (Patient and Public Contributor) \n* Mrs Helen Gregory-Osborne (Patient and Public Contributor)",{"url":195,"alt":86,"width":87,"height":88},"robust-content-image-15.svg",{"sectionLabel":197},"Co-Applicants",{"type":93,"settings":199,"title":200,"text":201,"image":202,"sectionSettings":204},{"imgWidth":95,"imgPosition":90},"## Current research management team","* Loretta Davies\n* Heidi Fletcher\n* Miriam Tillmann-Morris\n* Akiko Greshon",{"url":203,"alt":86,"width":87,"height":88},"robust-content-image-10.svg",{"sectionLabel":205},"current research management team","\u002Fpages\u002Fabout.en",{"title":28},"pages\u002Fabout.en","2NlbXLmKPwvkidxuVUmSuhM0klxXI4x6ROoPvDpzNvE",{"id":211,"title":212,"body":76,"description":76,"extension":5,"meta":213,"navigation":15,"path":227,"seo":228,"stem":229,"__hash__":230},"contentPages\u002Fpages\u002Faccessibility.en.json","Accessibility statement",{"pageTitle":212,"pageMetadata":214,"page_content":215},{"htmlTitle":212,"htmlDesc":212},[216,222],{"type":81,"title":217,"image":218,"settings":220,"sectionSettings":221},"# Accessibility statement",{"url":219,"alt":86,"width":87,"height":88},"robust-header-image-4.svg",{"imgPosition":90},{"sectionLabel":212},{"type":223,"text":224,"sectionSettings":225},"text","This study is committed to ensuring digital accessibility for people with disabilities. We are continually improving the user experience for everyone, and applying the relevant accessibility standards.\n\n## Conformance status\n\nThe \u003Ca href=\"https:\u002F\u002Fwww.w3.org\u002FWAI\u002Fstandards-guidelines\u002Fwcag\u002F\" target=\"_blank\">Web Content Accessibility Guidelines (WCAG)\u003C\u002Fa> define requirements for designers and developers to improve accessibility for people with disabilities. It defines three levels of conformance: Level A, Level AA, and Level AAA. \n\n**This site is conformant with WCAG 2.2 level AA** and **partially conformant with WCAG 2.2 level AAA**. Partially conformant means that some parts of the content do not fully conform to the AAA accessibility standard.\n\n### Specific exceptions to WCAG 2.2 level AA compliance\n\n* Third party frameworks used to build this app - e.g. \u003Ca href=\"https:\u002F\u002Fnuxtjs.org\u002F\" target=\"_blank\">Nuxt\u003C\u002Fa> - may contain some minor accessibility issues which are not editable by Morph. This includes, for instance, CSS loading animations the duration of which has been to set to longer than 5 seconds. We have attempted to ensure that these exceptions do not impact negatively on user experience.\n\n## Accessibility Features\n\n- All page content can be navigated using keyboard only\n- Skip to main content link available on all pages\n- ARIA labels and landmarks for screen reader users\n- Semantic HTML structure throughout\n- Sufficient color contrast ratios (minimum 4.5:1 for normal text)\n- Respects user preferences for reduced motion\n- Form labels and error messages clearly associated with inputs\n- Video content includes transcripts\n- Focus indicators are visible on all interactive elements\n\n## Design Decisions\n\n**Focus Indicators:** We rely on browser default focus indicators rather than custom styling. This approach ensures focus is always visible on all interactive elements and allows user-applied customisation through system-wide assistive technology to work as expected without interference.\n\n**Keyboard Navigation:** When using in-page content links with the keyboard, focus is applied to the target content for screen readers and keyboard users. The page does not auto-scroll to prevent disorientation, allowing users to control their scrolling experience.\n\n## Technical Specifications\n\nThis website's accessibility relies on the following technologies:\n\n- HTML5\n- CSS3\n- JavaScript\n- ARIA (Accessible Rich Internet Applications)\n\nThe website is designed to be compatible with assistive technologies including screen readers.\n\n## Testing\n\nThis website has been tested for accessibility using:\n\n- Keyboard-only navigation\n- Multiple screen readers (NVDA, VoiceOver)\n- Automated testing tools\n- Manual testing against WCAG 2.2 Level AA and AAA criteria\n\nWe have made every effort to ensure that all content is accessible, although we are aware of minor inconsistencies in how some screen readers handle complex features such as video transcripts.\n\nWhen navigating inside a page using the keyboard, the page content links do not scroll to the target content. However, focus is applied to the target content so screen readers will be directed to the appropriate content.\n\n## Limitations (Level AAA Only)\n\n**Focus Appearance (WCAG 2.4.13 - Level AAA):** While all focus indicators are visible (meeting Level AA requirements), browser default focus indicators may not consistently meet the enhanced AAA requirements for focus appearance (minimum 2px thickness and 3:1 contrast ratio) across all browsers and contexts.\n\n**Target Size (WCAG 2.5.5 - Level AAA):** Some interactive elements such as checkboxes, do not meet the enhanced AAA requirement of 44px × 44px minimum target size. All interactive elements meet the Level AA requirements for basic usability and are appropriately spaced to minimize accidental activation.\n\n## Feedback\n\nWe welcome your feedback on the accessibility of this website. If you experience any difficulty accessing content or have suggestions for improvement, please contact us at admin@morph.co.uk.\n\n## Assessment Information\n\n- **Evaluation method:** Self-assessment\n- **Statement last reviewed:** February 2026\n- **WCAG version:** 2.2\n- **Conformance level:** Level AA (conformant), Level AAA (partially conformant)",{"sectionLabel":226},"Conformance status","\u002Fpages\u002Faccessibility.en",{"title":212},"pages\u002Faccessibility.en","F92h11DQChSQXZUcLk2OWqos6SPIY_8MKJz8dx-5rwM",{"id":232,"title":35,"body":76,"description":76,"extension":5,"meta":233,"navigation":15,"path":261,"seo":262,"stem":263,"__hash__":264},"contentPages\u002Fpages\u002Fcontact.en.json",{"pageTitle":35,"pageMetadata":234,"page_content":235},{"htmlTitle":35,"htmlDesc":35},[236,244],{"type":81,"title":237,"text":238,"image":239,"settings":241,"sectionSettings":242},"# Contact Us","If, at any time, you would like further information about this study you can email the ROBUST Study team",{"url":240,"width":87,"height":88},"robust-header-image-6.svg",{"imgPosition":90},{"textAlign":153,"sectionLabel":243},"Contact Us",{"type":109,"settings":245,"cards":248,"text":86,"sectionSettings":259},{"headerLevel":246,"headerFontSize":112,"maxCardsPerRow":246,"wholeClickable":30,"cardTheme":247,"alignCards":114,"alignCardContent":114},"2","white",[249,254],{"type":118,"title":250,"summary":251,"icon":252},"Team:","robust@ndorms.ox.ac.uk",{"iconName":253,"iconSize":121},"content-mail",{"type":118,"icon":255,"title":257,"summary":258},{"iconSize":121,"iconName":256},"content-mobile","Mobile:","07584 155471",{"textAlign":153,"sectionLabel":260},"Contact cards","\u002Fpages\u002Fcontact.en",{"title":35},"pages\u002Fcontact.en","i0fSBvBdAXFIIPujOJcFZrnpRBjG-5JEjG1K29-uSTk",{"id":266,"title":267,"body":76,"description":76,"extension":5,"meta":268,"navigation":15,"path":286,"seo":287,"stem":288,"__hash__":289},"contentPages\u002Fpages\u002Fcookies.en.json","Cookie Policy",{"pageTitle":267,"pageMetadata":269,"page_content":270},{"htmlTitle":267,"htmlDesc":267},[271,277,281],{"type":81,"title":272,"image":273,"settings":275,"sectionSettings":276},"# Cookie Policy",{"url":274,"alt":86,"width":87,"height":88},"robust-header-image-3.svg",{"imgPosition":90},{"sectionLabel":267},{"type":223,"text":278,"sectionSettings":279},"## Website Cookies\n\nOur website uses necessary and non-necessary cookies. The necessary cookies are required for the website to function the right way, and they do not collect any of your personally identifiable data.\n\nThe non-necessary cookies used on our websites are used for understanding how the website is used so that we can provide you with a better user experience and help speed up your future interactions with our website.\n\n### Types of cookies we use\n\n**Necessary**: Some cookies are essential for you to be able to experience the full functionality of our site. They allow us to keep track of your progress through the site as well as enabling access to core functionality such as video playback. They do not collect or store any personal information.\n\n**Non-necessary**: These cookies store information like the number of visitors to the website, the number of unique visitors, which pages of the website have been visited, the source of the visit etc. These data help us understand and analyse how well the website performs and where it needs improvement.\n\n### Specific cookies we use\n\n#### Vimeo:\n\nPages that embed a Vimeo video load the Vimeo player when the page opens, so the cookies below may be set as soon as you open such a page — you do not have to press play. Pages with no video do not set them. These cookies do not track individuals. If you accept cookies, then choose to opt out later these cookies will not be deleted, but will stop tracking data after you have opted out.\n\n##### Cookie name: Player\n\n**Purpose**: Stores preferences for vimeo player controls (i.e. volume, stream quality, captions).\n\n**Necessary**: no\n\n**Expires in**: 1 year\n\n##### Cookie name: Vuid\n\n**Purpose**: Vimeo-generated ID used for generating analytics information for the video owner.\n\n**Necessary**: no\n\n**Expires in**: 2 years\n\n##### Cookie name: __cf_bm\u002F player_clearance\n\n**Purpose**: Cookies set by Vimeo's own Cloudflare protection to tell real visitors from bots.\n\n**Necessary**: yes\n\n**Expires in**: 30 minutes\u002F 7 days\n\n#### Our hosting provider (Cloudflare):\n\nThis website is served through Cloudflare, which sets the cookies below on our own domain to protect the site. They are set on **every** page, whether or not it contains a video, and are required for the site to be served securely.\n\n##### Cookie name: cf_clearance\n\n**Purpose**: Records that your browser passed Cloudflare's bot\u002Fsecurity check, so you are not re-challenged on every page.\n\n**Necessary**: yes\n\n**Expires in**: up to 1 year\n\n##### Cookie name: _cfuvid\n\n**Purpose**: Cloudflare cookie used to enforce rate limiting rules.\n\n**Necessary**: yes\n\n**Expires in**: current session only\n\n#### Cookie Name: _ga, _ga*\n\n**Purpose**: Used by Google Analytics to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. Stores information anonymously and assigns a randomly generated number to identify unique visitors.\n\n**Necessary**: no\n\n**Expires in**:  2 years\n\n## LocalStorage data\n\nWe also store data in your browser to keep track of your cookie preferences. This is stored in [LocalStorage](https:\u002F\u002Fen.wikipedia.org\u002Fwiki\u002FWeb_storage). This data is anonymous, persistent and necessary for the functioning of the site.\n\n### LocalStorage Key: GDPR:accepted\n\n**Purpose**: This localStorage property records whether you have accepted non-necessary cookies from this website. It is set only once you make a choice.\n\n**Necessary**: yes\n\n**Expires in**: permanent\n\n### Vimeo Local Storage\n\nVimeo uses browser local storage to remember video player preferences (such as volume and playback settings). These storage items are functional, are not used for advertising and store no identifiable information.\n\nExample keys may include\n\n* LOCAL_STORAGE_ID_VIMEO_PLAYER\n* sync_active\n\n**Necessary**: yes\n\n**Expires in**: variable\n\n## How can I control my cookie preferences?\n\nYou can edit your cookie preferences by clicking the link 'View and edit cookie settings' in the section 'What is my current cookie consent status?' below.\n\nIf you decide to 'Opt out' of non-necessary cookies, they may remain in your browser but will no longer be used to send data about your visit to the third party analytics service.\n\nIn addition to this, different browsers provide different methods to block and delete cookies used by websites. You can change the settings of your browser to block\u002Fdelete the cookies. To find out more out more on how to manage and delete cookies, visit [wikipedia.org](https:\u002F\u002Fen.wikipedia.org\u002Fwiki\u002FHTTP_cookie), [www.allaboutcookies.org.](http:\u002F\u002Fwww.allaboutcookies.org\u002F)\n\n## Contact Us\n\nIf you have any questions about the content of this page or problems with the website, please contact us at: admin@morph.co.uk",{"sectionLabel":280},"Website Cookies",{"type":103,"text":282,"componentName":283,"sectionSettings":284},"## What is my current cookie consent status?","CookiesOptInOut",{"sectionLabel":285},"View and Edit Cookie Settings","\u002Fpages\u002Fcookies.en",{"title":267},"pages\u002Fcookies.en","yGNlTpyvWk1qIkiP2P-fvz-Xdjfl9brwp1G-JONPriA",{"id":291,"title":292,"body":76,"description":76,"extension":5,"meta":293,"navigation":15,"path":377,"seo":378,"stem":379,"__hash__":380},"contentPages\u002Fpages\u002Findex.en.json","Home page",{"pageTitle":294,"pageMetadata":295,"page_content":296},"The ROBUST Study",{"htmlTitle":294,"htmlDesc":294},[297,310,319,327,358],{"type":81,"title":298,"text":299,"image":300,"settings":302,"strapline":86,"links":303,"sectionSettings":307},"# The ROBUST Study","Strengthening programme for ambulant adolescents with cerebral palsy.",{"url":301,"alt":86,"width":87,"height":88},"robust-header-image-1.svg",{"imgWidth":95,"imgPosition":90},[304,306],{"title":305,"url":48,"external":15},"Participant Information Tool",{"title":41,"url":40,"external":15},{"sectionLabel":308,"customClass":309},"The TRIAL Study","page_header_bg_2",{"type":311,"text":312,"video":313,"sectionSettings":317},"text_and_video","## Please watch our animation",{"vimeoId":314,"videoTitle":315,"videoTranscript":316,"offlineVideo":86},"840079042\u002F06cee1fa67","ROBUST Participant Information Animation","The ROBUST study is trying to find out if a new exercise programme to strengthen the muscles of young people with cerebral palsy… works better than the usual physio exercises.\n\nAs children with cerebral palsy grow older, their bodies get bigger and the muscles in their legs become weaker. This can make it more difficult to do things like walking, climbing stairs or taking part in hobbies and sports.\n\nDoctors and physiotherapists think that special exercises to strengthen the muscles in the legs could help children and young people with cerebral palsy stay more active as they grow older.\n\nWe are asking lots of young people with cerebral palsy, from across the country, to take part in this study.\n\nHalf the young people will do the new ROBUST exercises… and half will do the usual physio exercises.\n\nThe group doing the ROBUST exercise programme will see a physio 6 times in 4 months to go through the exercises.\n\nYou will do the exercises at home, 3 times a week, with help if you need it.\n\nThe group doing the usual exercise programme will see a physiotherapist once to go through the exercises and agree which activities to do.\n\nTo make the study fair, neither you nor the doctors and physiotherapists can choose which treatment you have.\n\nIt is decided by a computer using a process called randomisation.\n\nWe want to find out which exercise programme works best.\n\nWe also want to find out if the ROBUST exercises give you more muscle soreness than usual exercises.\n\nIf you join the ROBUST Study, a physiotherapist will carry out some simple tests to look at the strength of the muscles in your legs and how fast you can walk.\n\nWe will ask some questions about your walking, how well you can do activities, how you feel and if you’ve missed any school.\n\nAfter 6 months you will come back to the hospital and a physiotherapist will carry out the same simple tests.\n\nWe will also send you the same set of questions by email or by post, at 6 months and at 12 months.\n\nYou don’t have to take part in the study.\n\nIf you do take part you can leave at any time.\n\nYou will still receive the usual physio treatment.\n\nBy taking part you will help us find out which exercises are best for young people with cerebral palsy.\n\nThe doctors, physiotherapists and research team are happy to answer any questions you have about joining the ROBUST study.",{"sectionLabel":318},"DRIFT Participant Information Animation",{"type":93,"settings":320,"title":321,"text":322,"image":323,"sectionSettings":325},{"imgWidth":95,"imgPosition":90},"## Background","Cerebral palsy (CP) is caused when babies around the time of their birth suffer brain injury from lack of oxygen in the brain. As they grow, children with CP develop stiff and weak muscles. They often have difficulty walking and moving and that makes it difficult for them to join in different activities.\n\nPhysiotherapy becomes a big part of their lives as it tries to train their muscles and help them participate in activities. When they reach their adolescent years and their body grows bigger the weakness of muscles in the legs becomes more of a problem. It is possible that a programme of exercises to strengthen their leg muscles could help them remain more active. We are not certain that young people with CP truly benefit from the time and effort they dedicate to doing these exercises. We are also not sure if this exercise might cause them too much discomfort and muscle soreness to be able to carry it out long-term.",{"url":324,"alt":86,"width":87,"height":88},"robust-content-image-4.svg",{"sectionLabel":326},"Background",{"type":109,"settings":328,"cards":329,"sectionSettings":356},{"headerLevel":111,"headerFontSize":112,"maxCardsPerRow":111,"wholeClickable":15,"numberedCards":30,"alignCards":153,"alignCardContent":153},[330,339,348],{"type":157,"image":331,"title":334,"summary":335,"links":336},{"url":332,"width":87,"height":333},"robust-card-image-1.svg",640,"Taking Part","Find out more about taking part in the study",[337],{"title":338,"url":26,"external":30,"target":30},"Go to 'Taking Part'",{"type":157,"image":340,"title":342,"summary":343,"links":344},{"url":341,"width":87,"height":333},"robust-card-image-2.svg","About the Study","Learn more about the study",[345],{"title":346,"url":347},"Go to 'About the Study'","\u002Fabout",{"type":157,"image":349,"title":243,"summary":351,"links":352},{"url":350,"width":87,"height":333},"robust-card-image-3.svg","Get in touch with the study team",[353],{"title":354,"url":355},"Get in touch","\u002Fcontact",{"sectionLabel":357},"Benefits of screening for type 1 diabetes:",{"type":359,"logos":360,"maxLogosPerRow":375,"sectionSettings":376},"text_and_logos",[361,365,368,372],{"url":362,"width":363,"alt":364},"\u002F2x\u002Foxford@2x.png",245,"University of Oxford logo",{"url":366,"width":363,"alt":367},"\u002F2x\u002Fnihr@2x.png","National Institute for Health and Care Research logo",{"url":369,"width":370,"alt":371},"\u002F2x\u002Foctru@2x.png",240,"Oxford Clinical Trials Research Unit logo",{"url":373,"width":363,"alt":374},"\u002F2x\u002Fsitu@2x.png","Surgical Intervention Trials Unit logo",4,{"textAlign":153},"\u002Fpages\u002Findex.en",{"title":292},"pages\u002Findex.en","tH_CpMj0Oq-fxcAVi69oXHFMkSRwANq2GhsNn4HBOdg",{"id":382,"title":383,"body":76,"description":76,"extension":5,"meta":384,"navigation":15,"path":398,"seo":399,"stem":400,"__hash__":401},"contentPages\u002Fpages\u002Fprivacy.en.json","Privacy policy",{"pageTitle":385,"pageMetadata":386,"page_content":387},"Privacy page",{"htmlTitle":383,"htmlDesc":383},[388,394],{"type":81,"title":389,"image":390,"settings":392,"sectionSettings":393},"# Privacy policy",{"url":391,"alt":86,"width":87,"height":88},"robust-header-image-9.svg",{"imgPosition":90},{"sectionLabel":383},{"type":223,"text":395,"sectionSettings":396},"This website has been designed and developed by Morph Media Limited specifically for this clinical trial. We understand that your privacy is important to you and that you care about how your personal data is used. We respect and value the privacy of all of our customers and suppliers’ data and will only collect and use personal data in ways that are described here, and in a way that is consistent with our obligations and your rights under the law.\n\n## 1. Information about us\n\nMorph Media Limited, a limited company (company number 13801210).\n\nMain trading address: 8 New Shambles, Kendal, LA9 4TS\n\nVAT Reg: 400 693 620\n\nData Protection Officer: Matthew Brook\n\nEmail address: info@morph.co.uk\n\nTelephone number: 01524 88 42 88\n\nPostal Address: 8 New Shambles, Kendal, LA9 4TS\n\n## 2. What does this policy cover?\n\nThis Privacy Policy relates specifically to this website only and explains how we use your personal data on the site: how it is collected, how it is held, and how it is processed. It also explains your rights under the law relating to your personal data.\n\n## 3. What is personal data?\n\nPersonal data is defined by the General Data Protection Regulation (EU Regulation 2016\u002F679) (the “GDPR”) as ‘any information relating to an identifiable person who can be directly or indirectly identified in particular by reference to an identifier’. Personal data is, in simpler terms, any information about you that enables you to be identified. Personal data covers obvious information such as your name and contact details, but it also covers less obvious information such as identification numbers, electronic location data, and other online identifiers. The personal data that we use is set out in Part 5, below.\n\n## 4. What are your rights?\n\nUnder the GDPR, you have the following rights, which we will always work to uphold:\n\n1. The right to be informed about our collection and use of your personal data. This Privacy Policy should tell you everything you need to know, but you can always contact us to find out more or to ask any questions using the details in Part 11.\n2. The right to access the personal data we hold about you. Part 10 will tell you how to do this.\n3. The right to have your personal data rectified if any of your personal data held by us is inaccurate or incomplete. Please contact us using the details in Part 11 to find out more.\n4. The right to be forgotten, i.e. the right to ask us to delete or otherwise dispose of any of your personal data that we have. Please contact us using the details in Part 11 to find out more.\n5. The right to restrict (i.e. prevent) the processing of your personal data.\n6. The right to object to us using your personal data for a particular purpose or purposes.\n7. The right to data portability. This means that, if you have provided personal data to us directly, we are using it with your consent or for the performance of a contract, and that data is processed using automated means, you can ask us for a copy of that personal data to re-use with another service or business in many cases.\n8. Rights relating to automated decision-making and profiling. We do not use your personal data in this way.\n\nFor more information about our use of your personal data or exercising your rights as outlined above, please contact us using the details provided in Part 11.\n\nFurther information about your rights can also be obtained from the Information Commissioner’s Office or your local Citizens Advice Bureau.\n\nIf you have any cause for complaint about our use of your personal data, you have the right to lodge a complaint with the Information Commissioner’s Office.\n\n## 5. What personal data do we collect when you visit this website?\n\nYou may visit the Site without telling us who you are or revealing any personally identifiable information about you. \n\nThe website is hosted by Cloudflare using their Workers service. Cloudflare maintains log data about events on its network. Some of this log data will include information about visitors to and\u002For authorized users of a customer’s domains, networks, websites, application programming interfaces (“APIs”), or applications. This metadata contains extremely limited personal data, most often in the form of IP addresses. Cloudflare process this type of information on behalf of its  customers in its main data centers in the U.S. and Europe for a limited period of time.\n\nFor full details of Cloudflare's approach to privacy and data protection is available using the following link, although please bear in mind that these are wide-ranging documents with many documents not directly relevant to the service we use: \u003Ca href=\"https:\u002F\u002Fwww.cloudflare.com\u002Fen-gb\u002Ftrust-hub\u002Fprivacy-and-data-protection\u002F\" target=\"_blank\">https:\u002F\u002Fwww.cloudflare.com\u002Fen-gb\u002Ftrust-hub\u002Fprivacy-and-data-protection\u002F\u003C\u002Fa>\n\nIf you use the Contact Form on this website, then a service called smtp2go will be used to pass your email on to the trial team. This will involve your email contents being logged with smtp2go for 5 days on a server within the EU, providing a temporary record in the event that we need to troubleshoot any issues.\n\n**Please note**: this Privacy policy does not cover handling of email content by the intended recipient(s).\n\n[Cookie Policy](\u002Fcookie-policy)\n\n## 6. How do we use your personal data?\n\nUnder the GDPR, we must always have a lawful basis for using personal data. This may be because the data is necessary for our performance of a contract with you, because you have consented to our use of your personal data, or because it is in our legitimate business interests to use it. Your personal data may be used for one of the following purposes:\n\n* IP addresses are required by Cloudflare to troubleshoot a number of issues, such as connectivity issues, tracking down specific HTTP responses, tracking DDoS attacks.\n\n## 7. How long will we keep your personal data?\n\nCloudflare processes metadata, including IP addresses, for a limited period of time. Where the technical logs described in Part 10 are kept, they are held for no more than 7 days and are then deleted automatically.\n\n## 8. How and where do we store or transfer your personal data?\n\nWe may store or transfer some or all of your personal data in countries that are not part of the European Economic Area (the “EEA” consists of all EU member states, plus Norway, Iceland, and Liechtenstein). These are known as “third countries” and may not have data protection laws that are as strong as those in the UK and\u002For the EEA. Morph's relationship with Cloudflare with regard to personal data is covered by Cloudflare's standard Data Processing Addendum \n\u003Ca href=\"https:\u002F\u002Fwww.cloudflare.com\u002Fen-gb\u002Fcloudflare-customer-dpa\u002F\" target=\"_blank\">https:\u002F\u002Fwww.cloudflare.com\u002Fen-gb\u002Fcloudflare-customer-dpa\u002F\u003C\u002Fa> which ensures that your personal data is treated just as safely and securely as it would be within the UK and under the GDPR.\n\n## 9. Do we share your personal data?\n\nNo.\n\n## 10. How can I access my personal data?\n\nOur hosting provider may keep short-lived technical logs of requests made to this website, and these can include IP addresses. Where such logs are kept they are held for no more than 7 days and are then deleted automatically. Morph staff can view them in order to diagnose faults with the site, but we do not use them to identify individual visitors and we do not link them to any other information we hold.\n\n## 11. How do I contact you?\n\nTo contact us about anything to do with your personal data and data protection, including to make a subject access request, please use the following details (for the attention of Matthew Brook):\n\nEmail address: info@morph.co.uk\n\nTelephone number: 01524 88 42 88\n\nPostal Address: 8 New Shambles, Kendal, LA9 4TS\n\n## 12. Changes to this Privacy Policy\n\nWe may change this Privacy Policy from time to time. This may be necessary, for example, if the law changes, or if we change our business in a way that affects personal data protection. Any changes will be made available on this website.",{"sectionLabel":397},"Content","\u002Fpages\u002Fprivacy.en",{"title":383},"pages\u002Fprivacy.en","un-Z06WR3MpSfmyQ518gd6l7Rt5IMuh0ahfim546JMc",{"id":403,"title":32,"body":76,"description":76,"extension":5,"meta":404,"navigation":15,"path":442,"seo":443,"stem":444,"__hash__":445},"contentPages\u002Fpages\u002Fresources.en.json",{"pageTitle":32,"pageMetadata":405,"page_content":406},{"htmlTitle":32,"htmlDesc":32},[407,414,421,433],{"type":81,"title":408,"text":409,"image":410,"settings":412,"sectionSettings":413},"# Resources","This page provides access to useful resources relating to the ROBUST Study.",{"url":411,"width":87,"height":88},"robust-header-image-8.svg",{"imgPosition":90},{"textAlign":153,"sectionLabel":32},{"type":93,"settings":415,"title":86,"text":416,"image":417,"sectionSettings":419},{"imgWidth":95,"imgPosition":90},"## Printable Information Leaflets\n\n**Click on the links below to download these documents.**\n\n\u003Ca href=\"\u002FROBUST ParentGuardian PIL_V5.0_09Jun2025.pdf\" download=\"ROBUST ParentGuardian PIL_V5.0_09Jun2025.pdf\">Parent\u002FGuardian Information Leaflet (PDF)\u003C\u002Fa>\n\n\u003Ca href=\"\u002FROBUST ConsulteeInformationLeaflet_V5.0_09Jun2025.pdf\" download=\"ROBUST ConsulteeInformationLeaflet_V5.0_09Jun2025.pdf\">Consultee Information Leaflet (PDF)\u003C\u002Fa>\n\n\u003Ca href=\"\u002FROBUST 16-18 Year Olds PIL_V5.0_09Jun2025.pdf\" download=\"ROBUST 16-18 Year Olds PIL_V5.0_09Jun2025.pdf\">16-18 Year Olds Participant Information Leaflet (PDF)\u003C\u002Fa>\n\n\u003Ca href=\"\u002FROBUST 12-15 Year Olds PIL_V5.0_09Jun2025.pdf\" download=\"ROBUST 12-15 Year Olds PIL_V5.0_09Jun2025.pdf\">12-15 Year Olds Participant Information Leaflet (PDF)\u003C\u002Fa>",{"url":418,"width":87,"height":88},"robust-content-image-9.svg",{"textAlign":153,"sectionLabel":420},"PIL PDF links",{"type":93,"settings":422,"title":86,"text":424,"image":425,"links":427,"sectionSettings":431},{"imgWidth":95,"imgPosition":90,"btnTheme":423},"primary-filled","## Patient Information Tool",{"url":426,"width":87,"height":88},"robust-content-image-20.svg",[428],{"title":429,"url":430},"Online Patient Information Tool","https:\u002F\u002Frobust-info.digitrial.com",{"textAlign":153,"sectionLabel":432},"Link to PIT",{"type":93,"settings":434,"title":86,"text":435,"image":436,"links":438,"sectionSettings":441},{"imgWidth":95,"imgPosition":90,"btnTheme":423},"## ROBUST App\n\nIf you have signed up to the ROBUST study and need to access the ROBUST App you can do so below.",{"url":437,"width":87,"height":88},"robust-content-image-17.svg",[439],{"url":55,"title":440,"external":15},"ROBUST App",{"textAlign":153,"sectionLabel":440},"\u002Fpages\u002Fresources.en",{"title":32},"pages\u002Fresources.en","82QffGQrllMqcj33xYiBx2SoAik7kwWRJhn_65zQ6z4",{"id":447,"title":25,"body":76,"description":76,"extension":5,"meta":448,"navigation":15,"path":482,"seo":483,"stem":484,"__hash__":485},"contentPages\u002Fpages\u002Ftaking-part.en.json",{"pageTitle":25,"pageMetadata":449,"page_content":450},{"htmlTitle":25,"htmlDesc":25},[451,458,466,473],{"type":81,"title":452,"text":453,"image":454,"settings":456,"sectionSettings":457},"# Taking part","This page explains the ROBUST Study for people who might be interested in joining.",{"url":455,"width":87,"height":88},"robust-header-image-5.svg",{"imgPosition":90},{"textAlign":153,"theme":113,"sectionLabel":86},{"type":93,"settings":459,"title":460,"text":461,"image":462,"sectionSettings":464},{"imgWidth":95,"imgPosition":90},"## General information","We have developed a new exercise programme, using resistance exercises, to strengthen the leg muscles in young people with CP. We have also tried to make the exercise programme interesting and fun so that young people will be happy to follow it for a long time.\n\nThe aim of this study is to assess if a specific exercise programme to strengthen the muscles of young people with cerebral palsy is better at improving walking and their ability to carry out daily activities, compared to usual physiotherapy exercises.",{"url":463,"width":87,"height":88},"robust-content-image-6.svg",{"textAlign":153,"sectionLabel":465},"General information",{"type":103,"componentName":467,"componentOptions":468,"text":470,"sectionSettings":471},"StudyLocationsMap",{"mapTitle":469},"UK","## Locations",{"textAlign":153,"sectionLabel":472},"Locations Map",{"type":93,"settings":474,"text":475,"title":476,"image":477,"links":478,"sectionSettings":481},{"imgWidth":95,"imgPosition":90,"btnTheme":423},"If you are considering taking part in the ROBUST study, please follow the link below to open the ROBUST Participant Information Tool. Here you can view the key information needed to decide whether to take part.","## Participant Information",{"url":426,"width":87,"height":88},[479],{"title":480,"url":48,"target":15},"Participant Information",{"textAlign":153,"sectionLabel":480},"\u002Fpages\u002Ftaking-part.en",{"title":25},"pages\u002Ftaking-part.en","JGYD7UiOnCM2fOd9llD6eCYTMZYIkXqYTqH5HXmWJYc",[],1789137739997]